The restructuring arrives during a period of turmoil at California-based 23andMe, which has recently included a high-profile ...

Concerns about 23andMe's business prospects is raising questions about the genetic testing company's customer data.

Concerns about 23andMe's business prospects is raising questions about the genetic testing company's customer data.

CEO Anne Wojcicki told investors on an earnings call Tuesday that the moves are “difficult but necessary actions that we ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0616 GMT – Mega Lifesciences is facing pressure from a ...

UK-based not-for-profit organisation Leasing Foundation has expanded its board with the appointment of Lauren McQuilken and ...

The genetic testing company 23andMe hasn't been doing so hot lately, watching its share price plummet more than 70% this year ...

The DNA testing company 23andMe is facing serious financial concerns and has announced major restructuring. CBS News ...

In a prepared statement, 23andMe CEO and co-founder Anne Wojcicki said the company was "taking these difficult but necessary ...

On Thursday, genetics-led consumer healthcare company 23andMe Holding Co. (NASDAQ:ME) announced a business restructuring to ...

Despite a revenue decline, 23andMe Holding Co (ME) focuses on cost-saving measures and recurring revenue growth to enhance financial stability.